A quantification of circulating tumor cells in patients with gastric cancer by telomerase-specific oncolytic adenoviral agents

A quantification of circulating tumor cells in patients with gastric cancer by telomerase-specific oncolytic adenoviral agents - A quantification of circulating tumor cells in gastric cancer patients by telomerase-specific oncolytic adenoviral agents

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004026

Enrollment

200

Registered

2010-08-10

Start date

2010-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Measurement of circulating tumor cell (CTC) in peripheral blood from patients with gastric cancer Measurement of circulating tumor cell (CTC) in peripheral blood from healthy volunteer

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Histologically proven adenocarcinoma of the stomach by endoscopic biopsy 2)Clinical solitary tumor 3)No prior treatment of endoscopic resection, chemotherapy or radiation therapy 4)Aged between 20-80 years old 5)Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 6)Sufficient organ function 7)Written informed consent

Exclusion criteria

Exclusion criteria: 1)Synchronous or metachronous malignancy. 2)Pregnant women. 3)Breast-feeding women. 4)Active or chronic viral hepatitis. 5)Active bacterial or fungous infection. 6)Diabetes mellitus. 7)Systemic administration of corticosteroids. 8)Unstable hypertension.

Design outcomes

Primary

Measure	Time frame
measured value of circulating tumor cell (CTC)in peripheral blood, overall survival and relapse-free survival	—

Secondary

Measure	Time frame
Tumor clinical factor, tumor pathological factor and patients background	—

Countries

Japan

Contacts

Public ContactHiroaki Ito, MD, PhD

Showa University Nothern Yokohama Hospital Digestive Disease Center

h.ito@showa-u.ac.jp045-949-7000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026